<DOC>
	<DOC>NCT01779492</DOC>
	<brief_summary>The purpose of this clinical trial is to compare the pharmacokinetic characteristics of GL2907 XL 20mg tablet and Oxycontin CR 10mg tablet.</brief_summary>
	<brief_title>A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers</brief_title>
	<detailed_description>GL2907 XL 20mg tablet is controlled released formulation which is made by GL Pharm Tech.</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>20~45 years old, Healthy Adult Male Subject Body Weight ≥ 50kg and Ideal Body Weight ≤ ±20% ALT or AST &gt; 1.25 times (Upper Normal Range) Total Bilirubin &gt; 1.5 times (Upper Normal Range) CPK &gt; 2 times (Upper Normal Range) BUN or Creatinine &gt; Normal Range Systolic BP &gt; 160mmHg or &lt; 80mmHg, Diastolic BP &gt; 100mmHg or &lt; 50mmHg</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Oxycodone, controlled release formulation</keyword>
</DOC>